| http://www.w3.org/ns/prov#value | - In accordance with the present invention, quantities of B7 molecules are delivered to cancerous (or otherwise diseased) cells by means of targeted drug units comprising a targeting antibody linked to a carrier such as a liposome or microcapsule containing B7 molecules or directly conjugated to the B7 molecule.
|
